|
chr20_+_19870209
|
4.290
|
NM_018993
|
RIN2
|
Ras and Rab interactor 2
|
|
chr7_-_87849341
|
3.430
|
|
SRI
|
sorcin
|
|
chr8_+_54764367
|
3.065
|
NM_170587
|
RGS20
|
regulator of G-protein signaling 20
|
|
chr20_+_19915716
|
2.866
|
|
RIN2
|
Ras and Rab interactor 2
|
|
chr16_+_68678150
|
2.851
|
NM_001793
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
chr21_-_27512668
|
2.331
|
NM_001136016
|
APP
|
amyloid beta (A4) precursor protein
|
|
chr6_+_121756744
|
2.253
|
NM_000165
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
chr4_-_90759446
|
2.187
|
NM_001146055
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
chr10_-_126849010
|
2.114
|
|
CTBP2
|
C-terminal binding protein 2
|
|
chr18_+_29027731
|
1.985
|
NM_001944
|
DSG3
|
desmoglein 3
|
|
chr14_-_61748510
|
1.817
|
NM_001017970
|
TMEM30B
|
transmembrane protein 30B
|
|
chr9_-_88715024
|
1.760
|
NM_177937
|
GOLM1
|
golgi membrane protein 1
|
|
chr3_-_189838673
|
1.739
|
|
LEPREL1
|
leprecan-like 1
|
|
chr9_+_75766777
|
1.674
|
NM_000700
|
ANXA1
|
annexin A1
|
|
chr9_+_75766794
|
1.577
|
|
ANXA1
|
annexin A1
|
|
chr12_+_48513012
|
1.526
|
NM_000289
|
PFKM
|
phosphofructokinase, muscle
|
|
chr4_+_89299874
|
1.473
|
NM_001165136
NM_017912
|
HERC6
|
hect domain and RLD 6
|
|
chr7_-_87849366
|
1.473
|
NM_003130
|
SRI
|
sorcin
|
|
chr3_-_189838907
|
1.464
|
NM_018192
|
LEPREL1
|
leprecan-like 1
|
|
chr3_-_15382874
|
1.445
|
NM_001018009
|
SH3BP5
|
SH3-domain binding protein 5 (BTK-associated)
|
|
chr3_+_135741576
|
1.403
|
NM_181897
|
PPP2R3A
|
protein phosphatase 2, regulatory subunit B'', alpha
|
|
chr5_+_96212167
|
1.321
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
chr9_+_79115548
|
1.307
|
NM_001097636
|
GCNT1
|
glucosaminyl (N-acetyl) transferase 1, core 2
|
|
chr1_+_183155173
|
1.304
|
NM_005562
NM_018891
|
LAMC2
|
laminin, gamma 2
|
|
chr1_-_170038055
|
1.304
|
NM_001204517
|
KIFAP3
|
kinesin-associated protein 3
|
|
chr2_-_151344145
|
1.279
|
NM_005168
|
RND3
|
Rho family GTPase 3
|
|
chr4_+_89299980
|
1.275
|
|
HERC6
|
hect domain and RLD 6
|
|
chr12_+_27175482
|
1.256
|
NM_004264
|
MED21
|
mediator complex subunit 21
|
|
chr5_+_140771482
|
1.255
|
NM_014004
NM_032088
|
PCDHGA8
|
protocadherin gamma subfamily A, 8
|
|
chr13_-_110802708
|
1.231
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
chr13_+_50070096
|
1.213
|
|
PHF11
|
PHD finger protein 11
|
|
chr10_+_48255223
|
1.206
|
NM_001040084
NM_001098845
|
ANXA8L2
ANXA8
ANXA8L1
|
annexin A8-like 2
annexin A8
annexin A8-like 1
|
|
chr2_-_56151273
|
1.204
|
NM_001039348
NM_001039349
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
chr10_+_47746919
|
1.170
|
NM_001630
|
ANXA8L2
ANXA8
|
annexin A8-like 2
annexin A8
|
|
chr10_-_47173917
|
1.148
|
NM_001040084
NM_001098845
|
ANXA8L2
ANXA8
ANXA8L1
|
annexin A8-like 2
annexin A8
annexin A8-like 1
|
|
chr12_+_13043955
|
1.140
|
NM_003979
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A
|
|
chr1_+_84630575
|
1.130
|
NM_001242860
NM_001242861
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
chr17_+_7942351
|
1.102
|
NM_001039130
NM_001039131
NM_001141
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
chr1_-_170043608
|
1.091
|
NM_001204514
NM_001204516
NM_014970
|
KIFAP3
|
kinesin-associated protein 3
|
|
chr12_+_56915587
|
1.059
|
NM_002898
|
RBMS2
|
RNA binding motif, single stranded interacting protein 2
|
|
chr6_+_83072922
|
1.058
|
NM_006670
|
TPBG
|
trophoblast glycoprotein
|
|
chr18_+_61554938
|
1.051
|
NM_001143818
NM_002575
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
chr9_-_110252045
|
1.045
|
NM_004235
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
chr7_+_134576187
|
1.037
|
|
CALD1
|
caldesmon 1
|
|
chr2_-_175712276
|
1.033
|
NM_001206602
|
CHN1
|
chimerin (chimaerin) 1
|
|
chr6_+_29855349
|
1.026
|
|
HLA-H
|
major histocompatibility complex, class I, H (pseudogene)
|
|
chr10_-_126849066
|
1.024
|
NM_001329
|
CTBP2
|
C-terminal binding protein 2
|
|
chr9_-_14086901
|
1.006
|
|
NFIB
|
nuclear factor I/B
|
|
chr21_+_39628869
|
1.004
|
NM_170736
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15
|
|
chrX_-_114252132
|
0.998
|
NM_000640
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
chr1_+_220701547
|
0.996
|
NM_018650
|
MARK1
|
MAP/microtubule affinity-regulating kinase 1
|
|
chr1_+_150480486
|
0.961
|
NM_001202858
NM_004425
NM_022664
|
ECM1
|
extracellular matrix protein 1
|
|
chr19_-_4831711
|
0.959
|
NM_182919
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
chr22_+_45148437
|
0.937
|
NM_001017526
NM_001198726
NM_181335
|
ARHGAP8
|
Rho GTPase activating protein 8
|
|
chr18_+_61254533
|
0.935
|
NM_012397
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13
|
|
chr10_+_124145584
|
0.932
|
NM_001195608
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
|
chr20_-_14318200
|
0.930
|
NM_013281
NM_198391
|
FLRT3
|
fibronectin leucine rich transmembrane protein 3
|
|
chr2_-_85637486
|
0.926
|
NM_001747
|
CAPG
|
capping protein (actin filament), gelsolin-like
|
|
chr12_+_27175501
|
0.906
|
|
MED21
|
mediator complex subunit 21
|
|
chr18_+_61420276
|
0.904
|
NM_001040147
|
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7
|
|
chr5_+_140247767
|
0.894
|
NM_018902
NM_031861
|
PCDHA11
|
protocadherin alpha 11
|
|
chr15_-_63674074
|
0.889
|
NM_001218
NM_206925
|
CA12
|
carbonic anhydrase XII
|
|
chr3_-_149086884
|
0.883
|
|
TM4SF1
|
transmembrane 4 L six family member 1
|
|
chr18_-_47814691
|
0.877
|
NM_001101654
NM_014593
|
CXXC1
|
CXXC finger protein 1
|
|
chr6_+_150263120
|
0.861
|
NM_025217
|
ULBP2
|
UL16 binding protein 2
|
|
chr3_+_122044010
|
0.849
|
NM_005213
|
CSTA
|
cystatin A (stefin A)
|
|
chr11_+_67351276
|
0.841
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
chr15_-_72501017
|
0.833
|
|
PKM2
|
pyruvate kinase, muscle
|
|
chr19_+_13134782
|
0.826
|
|
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor)
|
|
chr8_+_132991171
|
0.824
|
|
EFR3A
|
EFR3 homolog A (S. cerevisiae)
|
|
chr3_+_62305395
|
0.822
|
NM_020685
|
C3orf14
|
chromosome 3 open reading frame 14
|
|
chr17_-_29641087
|
0.809
|
|
EVI2B
|
ecotropic viral integration site 2B
|
|
chr2_+_201473942
|
0.807
|
|
AOX1
|
aldehyde oxidase 1
|
|
chr11_-_17191287
|
0.805
|
NM_002645
|
PIK3C2A
|
phosphoinositide-3-kinase, class 2, alpha polypeptide
|
|
chr19_+_1026271
|
0.799
|
NM_004368
NM_201277
|
CNN2
|
calponin 2
|
|
chr15_-_63673918
|
0.798
|
|
CA12
|
carbonic anhydrase XII
|
|
chr12_+_32832272
|
0.786
|
|
DNM1L
|
dynamin 1-like
|
|
chr12_-_28124915
|
0.781
|
NM_002820
NM_198965
|
PTHLH
|
parathyroid hormone-like hormone
|
|
chr1_+_15764934
|
0.765
|
NM_007272
|
CTRC
|
chymotrypsin C (caldecrin)
|
|
chr17_-_29641094
|
0.752
|
NM_006495
|
EVI2B
|
ecotropic viral integration site 2B
|
|
chr1_+_84630374
|
0.737
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
chr21_+_37442298
|
0.735
|
|
CBR1
|
carbonyl reductase 1
|
|
chrX_-_10535476
|
0.733
|
NM_001193278
NM_001193279
NM_001193280
NM_001193281
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
|
chr12_+_32832209
|
0.729
|
|
DNM1L
|
dynamin 1-like
|
|
chr3_-_126327397
|
0.725
|
NM_001039783
|
TXNRD3NB
|
thioredoxin reductase 3 neighbor
|
|
chr15_+_32933869
|
0.696
|
NM_001144757
NM_003020
|
SCG5
|
secretogranin V (7B2 protein)
|
|
chr6_-_159240398
|
0.692
|
|
EZR
|
ezrin
|
|
chr6_-_159240399
|
0.683
|
|
EZR
|
ezrin
|
|
chr4_-_153303663
|
0.679
|
NM_001013415
|
FBXW7
|
F-box and WD repeat domain containing 7
|
|
chr2_-_190044330
|
0.675
|
NM_000393
|
COL5A2
|
collagen, type V, alpha 2
|
|
chr1_-_108786663
|
0.672
|
NM_001143989
|
NBPF4
NBPF6
|
neuroblastoma breakpoint family, member 4
neuroblastoma breakpoint family, member 6
|
|
chr1_+_81771844
|
0.671
|
|
LPHN2
|
latrophilin 2
|
|
chr2_-_86948244
|
0.669
|
NM_001198954
|
RNF103-CHMP3
|
RNF103-CHMP3 readthrough
|
|
chr18_-_61329113
|
0.664
|
NM_006919
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
chr7_+_134576150
|
0.655
|
NM_033139
NM_033140
|
CALD1
|
caldesmon 1
|
|
chr10_+_71561687
|
0.651
|
|
COL13A1
|
collagen, type XIII, alpha 1
|
|
chr11_-_102651321
|
0.651
|
NM_002425
|
MMP10
|
matrix metallopeptidase 10 (stromelysin 2)
|
|
chr22_+_23054862
|
0.649
|
|
IGLV3-21
IGLJ3
IGLC1
|
immunoglobulin lambda variable 3-21
immunoglobulin lambda joining 3
immunoglobulin lambda constant 1 (Mcg marker)
|
|
chr11_-_108464344
|
0.649
|
NM_015065
|
EXPH5
|
exophilin 5
|
|
chr12_+_32832128
|
0.646
|
NM_005690
NM_012062
NM_012063
|
DNM1L
|
dynamin 1-like
|
|
chr6_-_159240367
|
0.640
|
|
EZR
|
ezrin
|
|
chr4_+_55095263
|
0.629
|
NM_006206
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
chr16_+_82660390
|
0.628
|
NM_001220488
NM_001220489
NM_001220490
NM_001220491
NM_001220492
NM_001257
|
CDH13
|
cadherin 13, H-cadherin (heart)
|
|
chr3_+_11267666
|
0.624
|
NM_001098211
|
HRH1
|
histamine receptor H1
|
|
chr14_+_23305792
|
0.622
|
NM_004995
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
chr17_-_29641068
|
0.599
|
|
EVI2B
|
ecotropic viral integration site 2B
|
|
chrX_+_12994286
|
0.598
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
chr4_-_102268626
|
0.596
|
NM_000944
NM_001130691
NM_001130692
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
chr1_-_42965948
|
0.594
|
|
TMSB4XP1
|
thymosin beta 4, X-linked pseudogene 1
|
|
chr1_+_223889253
|
0.594
|
NM_001146068
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
chr13_+_111134933
|
0.590
|
|
COL4A2
|
collagen, type IV, alpha 2
|
|
chr12_-_15114495
|
0.575
|
NM_001175
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
chr14_+_23305816
|
0.573
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
chr7_+_89783688
|
0.571
|
NM_012449
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
|
chr1_-_161207879
|
0.567
|
NM_001077469
NM_001077470
NM_001077471
NM_001077472
NM_001077473
NM_001077474
NM_001077475
NM_001077476
NM_001077477
NM_001077478
NM_001077479
NM_001077480
NM_001077481
NM_001077482
NM_005122
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
chr5_+_140810126
|
0.565
|
NM_003735
NM_032094
|
PCDHGA12
|
protocadherin gamma subfamily A, 12
|
|
chr19_+_11200037
|
0.564
|
NM_000527
NM_001195798
NM_001195799
NM_001195800
NM_001195802
NM_001195803
|
LDLR
|
low density lipoprotein receptor
|
|
chr6_-_159240433
|
0.561
|
NM_001111077
|
EZR
|
ezrin
|
|
chr3_+_132036210
|
0.560
|
NM_001099
NM_001134194
|
ACPP
|
acid phosphatase, prostate
|
|
chr16_+_82660573
|
0.559
|
|
CDH13
|
cadherin 13, H-cadherin (heart)
|
|
chr11_+_67351065
|
0.550
|
NM_000852
|
GSTP1
|
glutathione S-transferase pi 1
|
|
chrX_+_118714297
|
0.549
|
NM_181777
|
UBE2A
|
ubiquitin-conjugating enzyme E2A
|
|
chr1_+_84609941
|
0.546
|
NM_182948
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
chr5_+_141346401
|
0.545
|
NM_001201365
NM_183399
|
RNF14
|
ring finger protein 14
|
|
chr19_+_3136026
|
0.544
|
NM_002068
|
GNA15
|
guanine nucleotide binding protein (G protein), alpha 15 (Gq class)
|
|
chr3_-_111314181
|
0.540
|
NM_024508
|
ZBED2
|
zinc finger, BED-type containing 2
|
|
chr4_+_47487230
|
0.537
|
NM_020453
|
ATP10D
|
ATPase, class V, type 10D
|
|
chr9_-_95298251
|
0.535
|
NM_001197295
NM_001197296
NM_001393
|
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific
|
|
chr13_-_37679800
|
0.528
|
NM_145203
|
CSNK1A1L
|
casein kinase 1, alpha 1-like
|
|
chr15_+_58430394
|
0.519
|
NM_020980
|
AQP9
|
aquaporin 9
|
|
chr22_-_17646176
|
0.518
|
NM_017829
|
CECR5
|
cat eye syndrome chromosome region, candidate 5
|
|
chr4_-_70826712
|
0.513
|
NM_001891
|
CSN2
|
casein beta
|
|
chr9_-_110251754
|
0.506
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
chr21_+_39628663
|
0.504
|
NM_002243
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15
|
|
chr6_+_29913400
|
0.500
|
|
|
|
|
chr10_-_33623771
|
0.492
|
NM_001024628
NM_001024629
NM_001244972
NM_001244973
NM_003873
|
NRP1
|
neuropilin 1
|
|
chr10_+_71561643
|
0.492
|
NM_001130103
NM_080798
NM_080800
NM_080801
NM_080802
NM_080805
|
COL13A1
|
collagen, type XIII, alpha 1
|
|
chr3_+_132316080
|
0.487
|
NM_016557
|
CCRL1
|
chemokine (C-C motif) receptor-like 1
|
|
chr22_-_43036606
|
0.484
|
NM_001165877
|
ATP5L2
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G2
|
|
chr14_-_60632019
|
0.483
|
|
DHRS7
|
dehydrogenase/reductase (SDR family) member 7
|
|
chr2_-_215896809
|
0.482
|
NM_015657
|
ABCA12
|
ATP-binding cassette, sub-family A (ABC1), member 12
|
|
chr3_-_69037498
|
0.481
|
|
C3orf64
|
chromosome 3 open reading frame 64
|
|
chr1_-_150978879
|
0.479
|
NM_001163259
NM_001163260
NM_001040217
|
FAM63A
|
family with sequence similarity 63, member A
|
|
chr11_+_114167168
|
0.478
|
|
NNMT
|
nicotinamide N-methyltransferase
|
|
chr8_-_80993009
|
0.478
|
NM_001025252
|
TPD52
|
tumor protein D52
|
|
chr3_-_189840225
|
0.476
|
NM_001134418
|
LEPREL1
|
leprecan-like 1
|
|
chr2_-_161056762
|
0.473
|
|
ITGB6
|
integrin, beta 6
|
|
chr9_-_14398981
|
0.466
|
NM_001190738
|
NFIB
|
nuclear factor I/B
|
|
chr9_-_117880411
|
0.463
|
NM_002160
|
TNC
|
tenascin C
|
|
chr3_+_159557649
|
0.456
|
NM_001197109
|
SCHIP1
|
schwannomin interacting protein 1
|
|
chr19_-_14785626
|
0.456
|
NM_032571
|
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3
|
|
chr18_+_61442611
|
0.453
|
NM_003784
|
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7
|
|
chr8_-_95274520
|
0.450
|
|
GEM
|
GTP binding protein overexpressed in skeletal muscle
|
|
chr2_-_219031646
|
0.447
|
NM_000634
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
chr7_+_89783789
|
0.447
|
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
|
chr4_-_102267952
|
0.445
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
chr11_+_101983170
|
0.442
|
NM_001195045
|
YAP1
|
Yes-associated protein 1
|
|
chr12_+_29302132
|
0.440
|
|
FAR2
|
fatty acyl CoA reductase 2
|
|
chr5_+_173472692
|
0.440
|
NM_015980
|
HMP19
|
HMP19 protein
|
|
chr3_+_159557745
|
0.439
|
|
SCHIP1
|
schwannomin interacting protein 1
|
|
chr7_+_90338711
|
0.436
|
NM_012395
|
CDK14
|
cyclin-dependent kinase 14
|
|
chr3_-_169587598
|
0.434
|
NM_024727
|
LRRC31
|
leucine rich repeat containing 31
|
|
chr6_+_26501448
|
0.433
|
NM_001732
|
BTN1A1
|
butyrophilin, subfamily 1, member A1
|
|
chr15_+_94841429
|
0.432
|
NM_001159643
NM_018349
|
MCTP2
|
multiple C2 domains, transmembrane 2
|
|
chr19_+_14491920
|
0.432
|
NM_001025160
NM_001784
NM_078481
|
CD97
|
CD97 molecule
|
|
chr1_+_84630014
|
0.431
|
NM_001242857
NM_001242858
NM_001242859
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
chr8_-_6420454
|
0.431
|
NM_001118887
NM_001118888
NM_001147
|
ANGPT2
|
angiopoietin 2
|
|
chr1_-_152297678
|
0.429
|
NM_002016
|
FLG
|
filaggrin
|
|
chr16_+_68771192
|
0.427
|
NM_004360
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
chr11_-_88070840
|
0.427
|
|
CTSC
|
cathepsin C
|
|
chr12_+_79258517
|
0.425
|
|
SYT1
|
synaptotagmin I
|
|
chr1_+_74701070
|
0.424
|
NM_015978
|
TNNI3K
|
TNNI3 interacting kinase
|
|
chr19_-_4400470
|
0.424
|
NM_001199943
NM_003025
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
chr6_-_32784727
|
0.423
|
NM_002120
|
HLA-DOB
|
major histocompatibility complex, class II, DO beta
|
|
chr12_-_50595303
|
0.422
|
NM_001243775
|
LIMA1
|
LIM domain and actin binding 1
|
|
chrX_-_63005212
|
0.420
|
NM_001173479
|
ARHGEF9
|
Cdc42 guanine nucleotide exchange factor (GEF) 9
|
|
chr7_+_76026819
|
0.420
|
NM_007155
|
ZP3
|
zona pellucida glycoprotein 3 (sperm receptor)
|
|
chr21_+_37442221
|
0.419
|
NM_001757
|
CBR1
|
carbonyl reductase 1
|
|
chr9_-_14314036
|
0.419
|
NM_001190737
NM_005596
|
NFIB
|
nuclear factor I/B
|
|
chr3_+_158787040
|
0.418
|
NM_001197113
NM_001197114
NM_001042705
NM_001042706
NM_001197100
|
IQCJ-SCHIP1
IQCJ
|
IQCJ-SCHIP1 readthrough
IQ motif containing J
|
|
chr1_-_85742586
|
0.416
|
NM_003921
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
chr10_+_124151818
|
0.414
|
NM_021622
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
|
chr11_-_102668892
|
0.414
|
NM_001145938
NM_002421
|
MMP1
|
matrix metallopeptidase 1 (interstitial collagenase)
|
|
chr1_-_153363544
|
0.414
|
NM_002964
|
S100A8
|
S100 calcium binding protein A8
|
|
chr15_-_60690115
|
0.411
|
NM_001002857
NM_001002858
NM_001136015
NM_004039
|
ANXA2
|
annexin A2
|
|
chr8_-_27941387
|
0.410
|
NM_001010906
|
C8orf80
|
chromosome 8 open reading frame 80
|
|
chr4_-_187644983
|
0.409
|
NM_005245
|
FAT1
|
FAT tumor suppressor homolog 1 (Drosophila)
|
|
chr1_+_35220647
|
0.409
|
NM_005268
|
GJB5
|
gap junction protein, beta 5, 31.1kDa
|
|
chr5_+_102201526
|
0.408
|
NM_000919
NM_001177306
NM_138766
NM_138821
NM_138822
|
PAM
|
peptidylglycine alpha-amidating monooxygenase
|
|
chr19_+_35645640
|
0.408
|
NM_144779
NM_001164605
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
chr12_+_13349720
|
0.408
|
|
EMP1
|
epithelial membrane protein 1
|
|
chr19_-_11689765
|
0.405
|
NM_001111035
NM_001111036
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
chr16_+_81812899
|
0.405
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
chr8_-_95274540
|
0.402
|
NM_005261
NM_181702
|
GEM
|
GTP binding protein overexpressed in skeletal muscle
|
|
chr16_+_81812897
|
0.400
|
NM_002661
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
chr15_+_64680002
|
0.400
|
NM_016213
|
TRIP4
|
thyroid hormone receptor interactor 4
|
|
chr19_+_35645614
|
0.399
|
NM_014164
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
chr14_-_60632058
|
0.399
|
NM_016029
|
DHRS7
|
dehydrogenase/reductase (SDR family) member 7
|
|
chr2_-_56150862
|
0.397
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
chr1_-_152009440
|
0.395
|
|
S100A11
|
S100 calcium binding protein A11
|
